Hopital Ambroise Pare

Research site

France 6 Rue Desiree Clary, 13003 Marseille, France

Hormone receptor positive HER2 negative breast cancer
Adult patients

About Specializations

Hopital Ambroise Pare in Marseille, France specialises in clinical trials of conditions such as Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.

Hormone receptor positive HER2 negative breast cancer

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

6 Rue Desiree Clary13003 MarseilleFrance

Open in maps ↗

Recruiting now: no trials
Conditions studied: 1

More sites in Marseille France

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Registered drug

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Everolimus
Sponsor:Unicancer

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites